In the Tricarboxylic Acid (TCA) cycle, two carbon atoms are released in the form of CO2. From which molecule are these carbon atoms derived?
Which complex of the electron transport chain reacts directly with O2?
In vivo control of the citric acid cycle is effected by:
What is the mechanism of action of 2,4-Dinitrophenol?
Which molecule is required in anabolic reactions?
Barbiturates act on which step of the mitochondrial respiratory chain?
Various compounds are added to mitochondria having a tightly coupled oxidative phosphorylation system. Addition of which of the following substrates will generate the least amount of ATP?
Which cellular compartment contains the maximum number of Krebs cycle enzymes?
What is the major metabolic fuel for the head in starvation?
What is the source of energy in the Krebs cycle?
Explanation: **Explanation:** The TCA cycle (Krebs cycle) is the final common pathway for the oxidation of carbohydrates, lipids, and proteins. The cycle begins with the condensation of a 2-carbon **Acetyl CoA** with a 4-carbon **Oxaloacetate (OAA)** to form a 6-carbon Citrate. **Why Acetyl CoA is correct:** The primary purpose of the TCA cycle is to completely oxidize the acetyl group of Acetyl CoA. During one turn of the cycle, two carbon atoms enter as Acetyl CoA, and two carbon atoms are subsequently released as **CO₂**. These decarboxylation steps are catalyzed by: 1. **Isocitrate Dehydrogenase:** Converts Isocitrate (6C) to α-Ketoglutarate (5C). 2. **α-Ketoglutarate Dehydrogenase:** Converts α-Ketoglutarate (5C) to Succinyl CoA (4C). While the specific carbon atoms released in one turn technically originate from the OAA backbone due to the symmetry of molecules, the net stoichiometry dictates that for every Acetyl CoA that enters, two carbons must leave to maintain the balance. **Why the other options are incorrect:** * **Oxaloacetate:** This is the "catalyst" of the cycle. It is consumed in the first step but regenerated in the final step. It is not the net source of the carbon lost as CO₂. * **Succinyl CoA & Fumarate:** These are intermediate 4-carbon compounds. By the time the cycle reaches these stages, both CO₂ molecules have already been released. **High-Yield NEET-PG Pearls:** * **Rate-limiting enzyme:** Isocitrate Dehydrogenase. * **Energy Yield:** One turn of the TCA cycle produces **10 ATP** (3 NADH = 7.5, 1 FADH₂ = 1.5, 1 GTP = 1). * **Inhibitor:** **Fluoroacetate** inhibits Aconitase; **Arsenite** inhibits α-Ketoglutarate Dehydrogenase. * **Location:** All enzymes are in the mitochondrial matrix except **Succinate Dehydrogenase**, which is located on the inner mitochondrial membrane (also part of Complex II of ETC).
Explanation: **Explanation:** The Electron Transport Chain (ETC) consists of a series of protein complexes located in the inner mitochondrial membrane that facilitate the transfer of electrons to generate a proton gradient for ATP synthesis. **Why Complex IV is correct:** **Complex IV (Cytochrome c Oxidase)** is the terminal component of the ETC. It receives electrons from Cytochrome c and transfers them directly to **molecular oxygen (O₂)**, the final electron acceptor. This reaction reduces oxygen to form water ($H_2O$). Complex IV contains specific copper centers ($Cu_A$ and $Cu_B$) and hemes ($a$ and $a_3$) that facilitate this high-affinity binding with oxygen. **Why the other options are incorrect:** * **Complex I (NADH Dehydrogenase):** It accepts electrons from NADH and transfers them to Coenzyme Q (Ubiquinone). It does not interact with oxygen. * **Complex II (Succinate Dehydrogenase):** It accepts electrons from FADH₂ (derived from the TCA cycle) and transfers them to Coenzyme Q. It is the only complex that does not pump protons. * **Complex III (Cytochrome bc1 complex):** It transfers electrons from reduced Coenzyme Q to Cytochrome c. **High-Yield Clinical Pearls for NEET-PG:** * **Inhibitors of Complex IV:** Cyanide, Carbon Monoxide (CO), Hydrogen Sulfide ($H_2S$), and Azides. These are "deadly" because they halt the entire chain by blocking the final step. * **P/O Ratio:** For every NADH entering at Complex I, ~2.5 ATP are generated; for every FADH₂ entering at Complex II, ~1.5 ATP are generated. * **Site of ROS:** While Complex IV reduces oxygen to water, Complexes I and III are the primary sites where "leakage" of electrons occurs, leading to the formation of Superoxide radicals (Reactive Oxygen Species).
Explanation: **Explanation:** The Citric Acid Cycle (TCA cycle) is the central metabolic pathway for energy production. Its rate is primarily determined by the **energy status of the cell**, signaled by the ratios of ATP/ADP and NADH/NAD+. **Why ATP is the Correct Answer:** ATP acts as a potent **allosteric inhibitor** of key rate-limiting enzymes in the TCA cycle, specifically **Isocitrate Dehydrogenase** and the **α-Ketoglutarate Dehydrogenase complex**. When cellular energy levels are high (high ATP), the cycle slows down to prevent unnecessary oxidation of fuel. Conversely, high levels of ADP (signaling energy depletion) act as an allosteric activator, speeding up the cycle. **Analysis of Incorrect Options:** * **A. Acetyl CoA:** While it is a substrate, it primarily regulates the *Pyruvate Dehydrogenase (PDH) complex* (inhibiting it) rather than the TCA cycle itself. * **B. Coenzyme A:** This is a cofactor/substrate. Its availability can influence the rate, but it is not a primary regulatory "control" molecule in vivo. * **D. Citrate:** Citrate is an intermediate. While it provides feedback inhibition to *Phosphofructokinase-1 (PFK-1)* in Glycolysis, it is not the primary global controller of the TCA cycle's flux compared to the ATP/ADP ratio. **High-Yield NEET-PG Pearls:** 1. **Rate-Limiting Enzyme:** Isocitrate Dehydrogenase is the most important regulatory step. 2. **Inhibitors:** ATP and NADH. 3. **Activators:** ADP and **Ca²⁺** (especially in skeletal muscle during contraction). 4. **Amphibolic Nature:** The TCA cycle is both catabolic (energy production) and anabolic (providing precursors for gluconeogenesis and amino acid synthesis).
Explanation: ### Explanation **Mechanism of Action: Uncoupling of Oxidative Phosphorylation** The correct answer is **C**. 2,4-Dinitrophenol (DNP) acts as a **protonophore**. It is a lipophilic weak acid that can easily cross the inner mitochondrial membrane. It picks up protons ($H^+$) from the intermembrane space and carries them directly into the mitochondrial matrix, bypassing the $F_0F_1$ ATP synthase complex. This **dissipates the proton gradient** (proton motive force). Consequently, electron transport continues at a rapid rate (consuming oxygen), but the energy is released as **heat** instead of being captured as ATP. **Analysis of Incorrect Options:** * **A. Inhibition of electron transfer:** This is the mechanism of toxins like **Cyanide, Carbon Monoxide** (Complex IV), and **Rotenone** (Complex I). They stop both oxygen consumption and ATP synthesis. * **B. Inhibition of ATP synthase:** This is the mechanism of **Oligomycin**, which binds to the $F_0$ subunit, physically blocking the proton channel. * **D. Inhibition of ATP-ADP exchange:** This is the mechanism of **Atractyloside** and **Bongkrekic acid**, which inhibit the Adenine Nucleotide Translocase (ANT). **High-Yield Clinical Pearls for NEET-PG:** * **Physiological Uncoupler:** **Thermogenin** (UCP1) found in **brown adipose tissue** of neonates; it generates heat to maintain body temperature (non-shivering thermogenesis). * **Clinical Presentation:** DNP poisoning presents with **hyperthermia**, tachycardia, and diaphoresis. It was historically used as a weight-loss drug but was banned due to fatal hyperpyrexia. * **Aspirin Overdose:** High doses of salicylates act as uncouplers, explaining the fever seen in aspirin toxicity. * **Key Distinction:** Uncouplers **increase** oxygen consumption and the rate of the TCA cycle, but **decrease** ATP synthesis.
Explanation: ### Explanation The correct answer is **NADP (specifically in its reduced form, NADPH)**. **1. Why NADP is Correct:** In biochemistry, a clear distinction exists between catabolic and anabolic pathways regarding electron carriers. **Anabolic reactions** (biosynthesis) are reductive processes that require a source of high-energy electrons. **NADPH** (Nicotinamide Adenine Dinucleotide Phosphate) serves as the primary **reductant** or electron donor in these pathways. Major examples include fatty acid synthesis, cholesterol biosynthesis, and steroid hormone production. The Pentose Phosphate Pathway (HMP Shunt) is the primary source of NADPH in the body. **2. Why the Other Options are Incorrect:** * **NAD (NAD+):** This molecule is primarily involved in **catabolic reactions** (breakdown of glucose, fats, and proteins). It acts as an electron acceptor (oxidizing agent) to generate NADH, which then enters the electron transport chain to produce ATP. * **FAD:** Similar to NAD, Flavin Adenine Dinucleotide is an electron carrier used in **catabolic pathways** (like the TCA cycle and Beta-oxidation) to capture energy. * **FADP:** This is a **distractor**. While FAD and NADP exist, "FADP" is not a standard physiological coenzyme used in metabolic pathways. **3. High-Yield Clinical Pearls for NEET-PG:** * **Mnemonic:** **NAD** is for **D**egradation (Catabolism); **NADP** is for **P**roduction (Anabolism). * **Key NADPH Sources:** The HMP Shunt (via G6PD enzyme) and Malic Enzyme. * **Clinical Correlation:** **G6PD Deficiency** leads to hemolytic anemia because RBCs depend solely on NADPH to maintain **Reduced Glutathione**, which protects the cell from oxidative damage (Reactive Oxygen Species). * **Phagocytosis:** NADPH is essential for the **NADPH Oxidase** enzyme in neutrophils to create a "Respiratory Burst" to kill bacteria. Deficiency leads to Chronic Granulomatous Disease (CGD).
Explanation: ### Explanation **1. Why Option A is Correct:** The mitochondrial electron transport chain (ETC) consists of several protein complexes that transfer electrons to generate a proton gradient. **Barbiturates** (specifically Amobarbital/Amytal) act as potent inhibitors of **Complex I (NADH-Q oxidoreductase)**. They bind to the complex and block the transfer of electrons from the Iron-Sulfur (Fe-S) centers of Complex I to **Coenzyme Q (Ubiquinone)**. This arrest of the electron flow prevents the establishment of a proton gradient, thereby inhibiting ATP synthesis. **2. Why Other Options are Incorrect:** * **Option B (Complex II to Co-enzyme Q):** This step is inhibited by agents like **Carboxin** and **Malonate** (a competitive inhibitor of Succinate Dehydrogenase). Barbiturates do not affect Complex II. * **Option C (Co-enzyme Q to Complex III):** This transfer is blocked by **Antimycin A** and **British Anti-Lewisite (BAL)**. * **Option D (Cytochrome C to Complex IV):** This terminal step (Cytochrome c oxidase) is inhibited by classic "cellular poisons" such as **Cyanide (CN⁻)**, **Carbon Monoxide (CO)**, **Sodium Azide**, and **Hydrogen Sulfide (H₂S)**. **3. Clinical Pearls & High-Yield Facts for NEET-PG:** * **Rotenone** (an insecticide) and **Piericidin A** (an antibiotic) also inhibit the same step as Barbiturates (Complex I → CoQ). * **Uncouplers vs. Inhibitors:** While barbiturates are *inhibitors* (stop electron flow), *uncouplers* (like 2,4-DNP or Thermogenin) allow electron flow to continue but dissipate the energy as heat instead of ATP. * **Oligomycin** is an inhibitor of **Complex V (ATP Synthase)**, not the respiratory chain itself. * **Mnemonic for Complex I Inhibitors:** "**BAR**p" — **B**arbiturates, **A**mital, **R**otenone, **P**iericidin A.
Explanation: ### Explanation The amount of ATP generated during oxidative phosphorylation depends on which complex of the Electron Transport Chain (ETC) the electrons enter. **1. Why "Malate with Rotenone" is correct:** Malate is oxidized to oxaloacetate by malate dehydrogenase, a process that generates **NADH**. Under normal conditions, NADH enters the ETC at **Complex I**. However, **Rotenone** is a potent inhibitor of Complex I. When Rotenone is present, the electrons from NADH cannot be transferred to Coenzyme Q. Consequently, the entire ETC is halted for NADH-linked substrates, resulting in **zero (least) ATP production**. **2. Analysis of Incorrect Options:** * **Malate (Option A):** In a tightly coupled system, Malate generates NADH, which yields approximately **2.5 ATP** per molecule as it passes through Complexes I, III, and IV. * **Succinate (Option B):** Succinate is oxidized by succinate dehydrogenase (**Complex II**), generating **FADH₂**. It bypasses Complex I and yields approximately **1.5 ATP** per molecule. * **Succinate with Rotenone (Option D):** Since Rotenone only inhibits Complex I, it has **no effect** on the oxidation of succinate. Succinate enters via Complex II and continues to produce **1.5 ATP**, making it a higher yield than Malate + Rotenone. ### High-Yield Clinical Pearls for NEET-PG * **Complex I Inhibitors:** Rotenone, Amobarbital (Amytal), and Piericidin A. * **Complex II Inhibitors:** Malonate (competitive inhibitor of succinate dehydrogenase) and Carboxin. * **Complex III Inhibitors:** Antimycin A and British Anti-Lewisite (BAL). * **Complex IV Inhibitors:** Cyanide, Carbon Monoxide (CO), Sodium Azide, and Hydrogen Sulfide ($H_2S$). * **Complex V (ATP Synthase) Inhibitor:** Oligomycin (closes the $F_0$ proton channel). * **Uncouplers:** 2,4-Dinitrophenol (DNP), Thermogenin (brown fat), and high doses of Aspirin. These dissipate the proton gradient, increasing oxygen consumption but stopping ATP synthesis.
Explanation: ### Explanation **1. Why Mitochondrial Matrix is Correct:** The Krebs cycle (TCA cycle) is the final common pathway for the oxidation of carbohydrates, lipids, and proteins. Most enzymes of this cycle—such as **Citrate synthase, Isocitrate dehydrogenase, and α-ketoglutarate dehydrogenase**—are located in a soluble form within the **mitochondrial matrix**. This localization ensures that the substrates and cofactors (NAD+ and FAD) are in close proximity to the enzymes and the subsequent Electron Transport Chain (ETC). *Note:* The only exception is **Succinate dehydrogenase**, which is embedded in the **inner mitochondrial membrane** (acting as Complex II of the ETC). However, since the vast majority are in the matrix, it remains the primary site. **2. Why Other Options are Incorrect:** * **Intermembrane Space:** This compartment primarily functions in proton gradient maintenance for ATP synthesis; it does not house metabolic cycle enzymes. * **Cytosol:** While glycolysis and fatty acid synthesis occur here, the TCA cycle is sequestered in the mitochondria to maintain metabolic efficiency and separate aerobic from anaerobic pathways. * **Ribosome:** These are sites of protein synthesis (translation) and have no role in energy-producing metabolic cycles. **3. High-Yield Clinical Pearls for NEET-PG:** * **Amphibolic Nature:** The TCA cycle is both catabolic (energy production) and anabolic (provides precursors for gluconeogenesis and heme synthesis). * **Rate-limiting Enzyme:** Isocitrate dehydrogenase is the key regulatory step. * **Energy Yield:** One turn of the TCA cycle produces **10 ATPs** (3 NADH = 7.5, 1 FADH₂ = 1.5, 1 GTP = 1). * **Vitamins Required:** The α-ketoglutarate dehydrogenase complex requires five cofactors: **T**hiamine (B1), **R**iboflavin (B2), **N**iacin (B3), **P**antothenic acid (B5), and **L**ipoic acid (Mnemonic: **T**ender **R**evolving **N**ashville **P**arty **L**ights).
Explanation: ### Explanation **1. Why Ketone Bodies are Correct:** The brain (head) has a high metabolic demand but cannot utilize free fatty acids (FFAs) because they are bound to albumin and cannot cross the **blood-brain barrier (BBB)**. During the initial stages of starvation, the brain relies on glucose produced via gluconeogenesis. However, in **prolonged starvation** (beyond 3–4 days), the liver produces ketone bodies (**acetoacetate and β-hydroxybutyrate**) from fatty acid oxidation. These ketone bodies are water-soluble, cross the BBB via monocarboxylate transporters, and are converted back into Acetyl-CoA to enter the TCA cycle. This shift is a crucial survival mechanism to spare muscle protein from being broken down for gluconeogenesis. **2. Why Other Options are Incorrect:** * **Glucose:** While glucose is the *obligate* fuel in the well-fed state, its availability is limited during starvation. The body shifts away from glucose to preserve it for red blood cells (which lack mitochondria). * **Free Fatty Acids:** As mentioned, FFAs cannot cross the BBB. While they are the major fuel for the liver and resting muscle during starvation, they cannot support brain metabolism. * **Proteins:** Proteins are not a "fuel" but a source of glucogenic amino acids. While protein breakdown occurs to provide substrates for gluconeogenesis, the brain does not directly oxidize proteins for energy. **3. High-Yield NEET-PG Pearls:** * **The "Switch":** After 3 days of starvation, the brain gets ~30% of its energy from ketones; by 40 days, this rises to **~70%**. * **Enzyme Note:** The brain can use ketones because it possesses the enzyme **Thiophorase** (Succinyl-CoA:3-ketoacid CoA transferase). The liver *cannot* use ketones because it lacks this enzyme. * **Priority:** In starvation, the heart and kidneys also utilize ketone bodies, sparing glucose for the brain and RBCs.
Explanation: **Explanation:** The Krebs cycle (Citric Acid Cycle) is the central metabolic pathway for the oxidation of acetyl-CoA. While the cycle produces a small amount of direct energy via substrate-level phosphorylation (GTP/ATP), its primary role is the generation of **reducing equivalents**. **Why NADH is the correct answer:** During one turn of the cycle, three molecules of **NADH** and one molecule of **FADH₂** are produced. These molecules act as electron carriers. NADH shuttles high-energy electrons to **Complex I** of the Electron Transport Chain (ETC). Through oxidative phosphorylation, each NADH molecule yields approximately **2.5 ATP**. Thus, NADH represents the primary "stored" energy source generated by the cycle to be converted into cellular fuel (ATP). **Analysis of Incorrect Options:** * **NAD+ (Option A):** This is the oxidized form of the coenzyme. It acts as an electron *acceptor* (oxidizing agent) rather than an energy source. * **NADP+ (Option B):** This is the oxidized form of Nicotinamide adenine dinucleotide phosphate, primarily used in anabolic pathways, not the Krebs cycle. * **NADPH (Option C):** This is the reduced form of NADP. It is primarily generated in the **Pentose Phosphate Pathway (HMP Shunt)** and is used for reductive biosynthesis (e.g., fatty acid synthesis) and neutralizing free radicals, rather than ATP production in the mitochondria. **High-Yield Clinical Pearls for NEET-PG:** * **Total ATP Yield:** One molecule of Acetyl-CoA entering the Krebs cycle yields **10 ATP** equivalents (3 NADH = 7.5; 1 FADH₂ = 1.5; 1 GTP = 1). * **Rate-Limiting Enzyme:** Isocitrate Dehydrogenase (inhibited by high ATP/NADH). * **Vitamin Requirements:** The cycle requires four B-vitamins: Thiamine (B1), Riboflavin (B2), Niacin (B3), and Pantothenic acid (B5). * **Amphibolic Nature:** The cycle is both catabolic (breaking down acetyl-CoA) and anabolic (providing precursors for amino acid and heme synthesis).
Bioenergetics and Thermodynamics
Practice Questions
ATP as Energy Currency
Practice Questions
Tricarboxylic Acid Cycle
Practice Questions
Electron Transport Chain
Practice Questions
Oxidative Phosphorylation
Practice Questions
Mitochondrial Diseases
Practice Questions
Uncouplers and Inhibitors of Oxidative Phosphorylation
Practice Questions
Shuttle Systems: Malate-Aspartate and Glycerol-Phosphate
Practice Questions
Energy Yield from Nutrients
Practice Questions
Metabolic Rate and Basal Metabolism
Practice Questions
Brown Adipose Tissue and Thermogenesis
Practice Questions
Oxygen Toxicity and Free Radicals
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free